Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Ferrlecit Generic Name & Formulations
Legal Class
Rx
General Description
Iron (as sodium ferric gluconate complex in sucrose) 12.5mg/mL; soln for IV inj or infusion; contains benzyl alcohol.
Pharmacological Class
Hematinic.
How Supplied
Single-dose vials (5mL)—10
Manufacturer
Ferrlecit Indications
Indications
Iron deficiency anemia in patients with chronic kidney disease receiving hemodialysis who are receiving supplemental epoetin therapy.
Ferrlecit Dosage and Administration
Adult
Give by IV infusion (diluted) or slow IV inj (undiluted). 125mg infused over 1 hour or by slow IV inj (at a rate of up to 12.5mg/min). Minimum cumulative dose: 1g given over 8 sequential dialysis sessions; usual max: 125mg/dose.
Children
<6yrs: not established. Give by IV infusion (diluted) over 1 hour. ≥6yrs: 1.5mg/kg per dose at 8 sequential dialysis sessions; max: 125mg/dose.
Ferrlecit Contraindications
Not Applicable
Ferrlecit Boxed Warnings
Not Applicable
Ferrlecit Warnings/Precautions
Warnings/Precautions
Risk of serious hypersensitivity reactions; monitor during and after administration for ≥30mins. Have personnel and resuscitative equipment readily available. Iron overload. Periodically monitor hematologic and iron parameters, and BP during and after administration. Elderly. Neonates/infants: risk of serious adverse reactions due to benzyl alcohol. Pregnancy, nursing mothers: consider alternative therapies without benzyl alcohol.
Ferrlecit Pharmacokinetics
See Literature
Ferrlecit Interactions
Interactions
May reduce absorption of concomitant oral iron preparations.
Ferrlecit Adverse Reactions
Adverse Reactions
Nausea, vomiting, diarrhea, inj site reaction, hypotension, cramps, hypertension, dizziness, dyspnea, chest pain, leg cramps, and pain; in children: also headache, tachycardia; hypersensitivity reactions.
Ferrlecit Clinical Trials
See Literature
Ferrlecit Note
Not Applicable
Ferrlecit Patient Counseling
See Literature
